These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 17996182)

  • 1. [Microalbuminuria accounts for the increased vascular disease risk in diabetic patients with metabolic syndrome].
    Gimeno-Orna JA; Molinero-Herguedas E; Lou-Arnal LM; Boned-Juliani B; Labrador-Fuster T; Guiu-Campos M
    Rev Esp Cardiol; 2007 Nov; 60(11):1202-5. PubMed ID: 17996182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of Type 2 diabetes and microalbuminuria on future cardiovascular events in patients with clinically manifest vascular disease from the Second Manifestations of ARTerial disease (SMART) study.
    Soedamah-Muthu SS; Visseren FL; Algra A; van der Graaf Y;
    Diabet Med; 2008 Jan; 25(1):51-7. PubMed ID: 18199132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Metabolic syndrome as a cardiovascular risk factor in patients with type 2 diabetes].
    Gimeno Orna JA; Lou Arnal LM; Molinero Herguedas E; Boned Julián B; Portilla Córdoba DP
    Rev Esp Cardiol; 2004 Jun; 57(6):507-13. PubMed ID: 15225497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased prevalence of microvascular complications in type 2 diabetes patients with the metabolic syndrome.
    Abdul-Ghani M; Nawaf G; Nawaf F; Itzhak B; Minuchin O; Vardi P
    Isr Med Assoc J; 2006 Jun; 8(6):378-82. PubMed ID: 16833164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Usefulness of microalbuminuria in the metabolic syndrome as a predictor of cardiovascular disease. Prospective study about 78 cases].
    Bendriss L; Lebbaq A; Jallal H; Mrani S; Khatouri A
    Ann Cardiol Angeiol (Paris); 2012 Feb; 61(1):15-9. PubMed ID: 21679922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association between metabolic syndrome, microalbuminuria and impaired renal function in the general population: impact on cardiovascular disease and mortality.
    Klausen KP; Parving HH; Scharling H; Jensen JS
    J Intern Med; 2007 Oct; 262(4):470-8. PubMed ID: 17875184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microalbuminuria presents the same vascular risk as overt CVD in type 2 diabetes.
    Gimeno-Orna JA; Molinero-Herguedas E; Sánchez-Vaño R; Lou-Arnal LM; Boned-Juliani B; Castro-Alonso FJ
    Diabetes Res Clin Pract; 2006 Oct; 74(1):103-9. PubMed ID: 16621114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Microalbuminuria and clinical proteinuria as the main predictive factors of cardiovascular morbidity and mortality in patients with type 2 diabetes].
    Gimeno Orna JA; Boned Juliani B; Lou Arnal LM; Castro Alonso FJ
    Rev Clin Esp; 2003 Nov; 203(11):526-31. PubMed ID: 14599392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women.
    Manson JE; Colditz GA; Stampfer MJ; Willett WC; Krolewski AS; Rosner B; Arky RA; Speizer FE; Hennekens CH
    Arch Intern Med; 1991 Jun; 151(6):1141-7. PubMed ID: 2043016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-reactive protein is a strong independent predictor of death in type 2 diabetes: association with multiple facets of the metabolic syndrome.
    Linnemann B; Voigt W; Nobel W; Janka HU
    Exp Clin Endocrinol Diabetes; 2006 Mar; 114(3):127-34. PubMed ID: 16636979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum uric acid level is associated with metabolic syndrome and microalbuminuria in Korean patients with type 2 diabetes mellitus.
    Kim ES; Kwon HS; Ahn CW; Lim DJ; Shin JA; Lee SH; Cho JH; Yoon KH; Kang MI; Cha BY; Son HY
    J Diabetes Complications; 2011; 25(5):309-13. PubMed ID: 21130003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brachial artery reactivity in asymptomatic patients with type 2 diabetes mellitus and microalbuminuria (from the Detection of Ischemia in Asymptomatic Diabetics-brachial artery reactivity study).
    Papaioannou GI; Seip RL; Grey NJ; Katten D; Taylor A; Inzucchi SE; Young LH; Chyun DA; Davey JA; Wackers FJ; Iskandrian AE; Ratner RE; Robinson EC; Carolan S; Engel S; Heller GV
    Am J Cardiol; 2004 Aug; 94(3):294-9. PubMed ID: 15276091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microalbuminuria: a common, independent cardiovascular risk factor, especially but not exclusively in type 2 diabetes.
    Donnelly R; Yeung JM; Manning G
    J Hypertens Suppl; 2003 Mar; 21(1):S7-12. PubMed ID: 12769161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microalbuminuria, cardiovascular risk factors, and secondary prevention of non-insulin-dependent diabetes.
    Jermendy G; Vörös P
    Postgrad Med J; 1995 Jan; 71(831):58. PubMed ID: 7772149
    [No Abstract]   [Full Text] [Related]  

  • 15. The usefulness of the International Diabetes Federation and the National Cholesterol Education Program's Adult Treatment Panel III definitions of the metabolic syndrome in predicting coronary heart disease in subjects with type 2 diabetes.
    Tong PC; Kong AP; So WY; Yang X; Ho CS; Ma RC; Ozaki R; Chow CC; Lam CW; Chan JC; Cockram CS
    Diabetes Care; 2007 May; 30(5):1206-11. PubMed ID: 17259472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of metabolic syndrome slows progression of diabetic nephropathy.
    Duran-Perez EG; Almeda-Valdes P; Cuevas-Ramos D; Campos-Barrera E; Muñoz-Hernandez L; Gomez-Perez FJ
    Metab Syndr Relat Disord; 2011 Dec; 9(6):483-9. PubMed ID: 21875335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of metabolic syndrome or type II diabetes mellitus on the occurrence of recurrent vascular events in hypertensive patients.
    Vlek AL; van der Graaf Y; Spiering W; Visseren FL;
    J Hum Hypertens; 2008 May; 22(5):358-65. PubMed ID: 18273039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of cardiovascular and total mortality in Chinese type 2 diabetic patients by the WHO definition for the metabolic syndrome.
    Ko GT; So WY; Chan NN; Chan WB; Tong PC; Li J; Yeung V; Chow CC; Ozaki R; Ma RC; Cockram CS; Chan JC
    Diabetes Obes Metab; 2006 Jan; 8(1):94-104. PubMed ID: 16367887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic syndrome is independently associated with microalbuminuria in type 2 diabetes.
    Esteghamati A; Rashidi A; Khalilzadeh O; Ashraf H; Abbasi M
    Acta Diabetol; 2010 Jun; 47(2):125-30. PubMed ID: 19479185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Microalbuminuria with Metabolic Syndrome among Aged Population.
    Li XH; Lin HY; Wang SH; Guan LY; Wang YB
    Biomed Res Int; 2016; 2016():9241278. PubMed ID: 27200378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.